9,370 followers
Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study. Immune thrombocytopenia (ITP) is an autoimmune disease defined by a low platelet count without any other cause of thrombocytopenia. ht